About this trial
This study aims to prospectively compare umbilical venous catheters (UVCs) and peripherally inserted central catheters (PICCs) in neonates, focusing on complications, catheter survival, and central line-associated bloodstream infection (CLABSI) rates
Eligibility criteria
Qualifiers
Neonates admitted to the neonatal intensive care unit (NICU) requiring central venous access.
Infants in whom either an umbilical venous catheter (UVC) or a peripherally inserted central catheter (PICC) was inserted for clinical indications (Parenteral nutrition, administration of intravenous medications (e.g., antibiotics, inotropes, anticonvulsants, fluids) and blood sampling for frequent labs, especially in critically ill neonates).
Catheter insertion performed within the first 28 days of life.
Disqualifiers
Neonates with major congenital anomalies (e.g.abdominal wall defects) that may interfere with catheter placement or outcomes.
Insertion site infection
Infants with severe coagulopathy or bleeding disorders contraindicating central catheter insertion.
Neonates who received both UVC and PICC simultaneously during the same admission.
Trial design
Treatments tested in this trial
- peripherally inserted central catheter insertion
- umbilical venous catheters insertion